GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
Stocks in this Quantisnow insightTechnology
Historical context for GDRX
Across the 9 sessions after earlier GDRX headlines, the stock closed higher 4 times and lower 5 times, with a median move of 2.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GDRX | SPY |
|---|---|---|---|
| Jan 29, 2026 | GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call | +2.6% | -0.2% |
| Jan 22, 2026 | GoodRx downgraded by Jefferies with a new price target | -0.4% | +0.5% |
| Jan 13, 2026 | Surescripts and GoodRx Partner to Advance Patient Price Transparency | -0.7% | -0.2% |
| Jan 8, 2026 | GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies | -2.1% | -0.0% |
| Jan 5, 2026 | GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill | +2.9% | +0.7% |
| Dec 17, 2025 | GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference | +0.7% | -1.1% |
Quantisnow market dataNASDAQ
GDRX
GoodRx Holdings Inc.
- Market cap
- 30-day
- Sector
- Technology
- Industry
- EDP Services
- Listed since
- 2020
Get push alerts for GDRX
Full GDRX profile on Quantisnow Follow GDRX and get a push notification the moment its next story breaks.